Senior Director, Mavacamten Medical Product Lead

Responsibilities:
- Develop and execute WW & US Medical Affairs strategy for Mavacamten (Camzyos) across all HCM indications (oHCM, nHCM), aligned to BMS cardiovascular strategy.
- Act as core global medical representative for WW & US Mavacamten Program Teams across cross-functional forums.
- Lead the cross-functional Asset/Indication Medical Strategy (AIMS) team; set direction and align deliverables across global markets.
- Oversee Mavacamten asset strategy across lifecycle: new indications, label expansions, and post-marketing evidence generation.
- Lead integrated evidence planning (IEPs), evidence gap identification, global medical data generation, and Investigator Sponsored Research (ISR) execution with reporting/publication and congress dissemination.
- Deliver WW & US Medical Communications plans (publications, symposia, scientific exchange; e.g., AHA/ACC/ESC/HFSA).
- Engage global KOLs/thought leaders and partner with Discovery, Clinical Research, Regulatory, and Health Outcomes; support pricing/reimbursement strategy.

Qualifications/Skills:
- MD/PharmD/PhD required; 8+ years pharma industry experience (Medical Affairs/Strategy, Clinical Research) in cardiovascular medicine; HCM/myosin inhibition expertise preferred.
- Strong analytical and evidence interpretation skills; strategy development, critical thinking, decision-making.
- Proven KOL engagement; experience leading global medical programs in matrixed worldwide organizations.
- Knowledge of drug development phases; launch experience preferred; travel ~20–30%.

Benefits (high level): Medical/dental/vision; wellbeing support; 401(k), disability/life insurance.

Application instruction: If the role doesn’t perfectly match your resume, apply anyway.